Lymphoma - Histopathology in changing clinical perspective

South African Medical Journal

Volumn 90, Issue 2 I, 2000, Pages 135-141

  Jacobs, Peter ^a  

^a Department of Haematology and Bone Marrow Transplantation Unit   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN;

ARTICLE; CANCER CLASSIFICATION; CANCER SURVIVAL; CARCINOGENESIS; HISTOPATHOLOGY; HONG KONG; IMMUNOPHENOTYPING; LYMPHOMA; SOUTH AFRICA; SURVIVAL RATE; TUMOR SUPPRESSOR GENE; UNITED KINGDOM;

ADULT; CYTOGENETICS; DISEASE-FREE SURVIVAL; FEMALE; HISTOLOGICAL TECHNIQUES; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0034124318     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Jacobs P, Wood L. The lymphomas: contemporary management Specialist Medicine 1998; 20(3): 16-26.
2. Gall EA, Mallory TB. Malignant Iymphoma: a dinico-pathologic survey of 618 cases. Am J Pathol 1942; 18:381-415.
3. Rappaport H, Winter WJ, Hicks EB. Follicular Iymphoma: a re-evaluation of its position in the scheme of malignant lymphoma, based on a survey of 253 cases. Cancer 1954; 9: 792-821.
4. Lukes RJ, Collins RD. Immunologic characterization of human malignant lymphomas. Cancer 1974; 34: 1483-1503,
5. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a Working Formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer 1982; 49: 2112-2135.
6. Lennert K, Mohri N, Stein H, Kaiserling E. The histopathology of malignant Iymphoma. Br J Haematol 1975; 31: Suppl, 193-203.
7. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 1993; 329: 987-994.
8. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-1392.
9. Weise NS. Geographical variation in the incidence of the leukemias and lymphomas. Natl Cancer Inst Monogr 1979; 53: 139-142.
10. Correa P, O'Conor GT. Geographic pathology of lymphoreticular tumors: summary of survey from the Geographic Pathology Committee on the International Union Against Cancer. J Natl Cancer Inst 1973; 50: 1609-1617.
11. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. Journal of the American Statistical Association 1958; 53: 457-481.
12. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's Jymphoma. The Non-Hodgkin's Lymphoma Classification Project Blood 1997; 87: 3909-3918.
13. Anderson JR, Weisenburger DD, Armitage JO, for the Non-Hodgkin's Lymphoma Classification Project. Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Ann Oncol 1998; 9: 717-720.
14. Jaffe ES, Harris NL, Diebold J, Muller-Hermelink HK. World Health Organization classification of neoplastic diseases of the hemalopoietic and lymphoid tissues: a progress report. Am J Clin Pathol 1999; 111: suppl 1, S8-S12.
15. Jacobs P. SASMO Clinical Trials Group: The haematologic malignancies. The Cape Doctor 1998; 38: 16.